| Mounir Y Borno, MD | |
|
4802 N Loop 289, Lubbock, TX 79416-3025 | |
| (806) 788-0040 | |
| (806) 788-0015 |
| Full Name | Mounir Y Borno |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 41 Years |
| Location | 4802 N Loop 289, Lubbock, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578566006 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | J8921 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lubbock Heart Hospital Lp | Lubbock, TX | Hospital |
| Covenant Medical Center | Lubbock, TX | Hospital |
| Cogdell Memorial Hospital | Snyder, TX | Hospital |
| Medical Arts Hospital | Lamesa, TX | Hospital |
| Brownfield Regional Medical Center | Brownfield, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Physicians Group | 0042476582 | 9 |
News Archive
A federal judge in Arizona has issued an injunction barring Arizona from enforcing a law that halts state money from flowing to Planned Parenthood, saying the women's health provider's challenge will likely succeed on a "freedom-of-choice" provision in Medicaid.
Using metabolic or molecular imaging to measure brain tumor patients' response to treatment is a powerful predictor of survival, notes a first-of-its-kind study presented at the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine professionals.
In an analysis that included more than 40,000 women exposed to the nausea medication metoclopramide in pregnancy, use of this drug was not associated with significantly increased risk of major congenital malformations overall, spontaneous abortion, and stillbirth, according to a study in the October 16 issue of JAMA.
BioDelivery Sciences International, Inc. today announced the approval of a New Drug Submission (NDS) by Health Canada, the regulatory authority in Canada, for ONSOLIS (fentanyl buccal soluble film) in the management of breakthrough pain in opioid-tolerant adult patients with cancer. ONSOLIS is the first product approved in Canada for this indication.
› Verified 8 days ago
| Entity Name | Lubbock Cardiology Specialists, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215910633 PECOS PAC ID: 9335047422 Enrollment ID: O20040326000981 |
News Archive
A federal judge in Arizona has issued an injunction barring Arizona from enforcing a law that halts state money from flowing to Planned Parenthood, saying the women's health provider's challenge will likely succeed on a "freedom-of-choice" provision in Medicaid.
Using metabolic or molecular imaging to measure brain tumor patients' response to treatment is a powerful predictor of survival, notes a first-of-its-kind study presented at the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine professionals.
In an analysis that included more than 40,000 women exposed to the nausea medication metoclopramide in pregnancy, use of this drug was not associated with significantly increased risk of major congenital malformations overall, spontaneous abortion, and stillbirth, according to a study in the October 16 issue of JAMA.
BioDelivery Sciences International, Inc. today announced the approval of a New Drug Submission (NDS) by Health Canada, the regulatory authority in Canada, for ONSOLIS (fentanyl buccal soluble film) in the management of breakthrough pain in opioid-tolerant adult patients with cancer. ONSOLIS is the first product approved in Canada for this indication.
› Verified 8 days ago
| Entity Name | Texas Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497014369 PECOS PAC ID: 0042476582 Enrollment ID: O20120727000066 |
News Archive
A federal judge in Arizona has issued an injunction barring Arizona from enforcing a law that halts state money from flowing to Planned Parenthood, saying the women's health provider's challenge will likely succeed on a "freedom-of-choice" provision in Medicaid.
Using metabolic or molecular imaging to measure brain tumor patients' response to treatment is a powerful predictor of survival, notes a first-of-its-kind study presented at the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine professionals.
In an analysis that included more than 40,000 women exposed to the nausea medication metoclopramide in pregnancy, use of this drug was not associated with significantly increased risk of major congenital malformations overall, spontaneous abortion, and stillbirth, according to a study in the October 16 issue of JAMA.
BioDelivery Sciences International, Inc. today announced the approval of a New Drug Submission (NDS) by Health Canada, the regulatory authority in Canada, for ONSOLIS (fentanyl buccal soluble film) in the management of breakthrough pain in opioid-tolerant adult patients with cancer. ONSOLIS is the first product approved in Canada for this indication.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mounir Y Borno, MD 4802 N Loop 289, Lubbock, TX 79416-3025 Ph: (806) 788-0040 | Mounir Y Borno, MD 4802 N Loop 289, Lubbock, TX 79416-3025 Ph: (806) 788-0040 |
News Archive
A federal judge in Arizona has issued an injunction barring Arizona from enforcing a law that halts state money from flowing to Planned Parenthood, saying the women's health provider's challenge will likely succeed on a "freedom-of-choice" provision in Medicaid.
Using metabolic or molecular imaging to measure brain tumor patients' response to treatment is a powerful predictor of survival, notes a first-of-its-kind study presented at the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine professionals.
In an analysis that included more than 40,000 women exposed to the nausea medication metoclopramide in pregnancy, use of this drug was not associated with significantly increased risk of major congenital malformations overall, spontaneous abortion, and stillbirth, according to a study in the October 16 issue of JAMA.
BioDelivery Sciences International, Inc. today announced the approval of a New Drug Submission (NDS) by Health Canada, the regulatory authority in Canada, for ONSOLIS (fentanyl buccal soluble film) in the management of breakthrough pain in opioid-tolerant adult patients with cancer. ONSOLIS is the first product approved in Canada for this indication.
› Verified 8 days ago
Mustafa Aly, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3615 19th St, Lubbock, TX 79410 Phone: 806-725-4130 | |
Dr. Nuvneet N/a Khandelwal, MD, MBA Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 4816 7th St, Lubbock, TX 79416 Phone: 432-230-3005 | |
Janice Stachowiak, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 3601 4th St, Lubbock, TX 79430 Phone: 806-743-3150 Fax: 806-743-3168 | |
M Alan Sharif, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4802 N Loop 289, Lubbock, TX 79416 Phone: 806-788-0040 Fax: 806-788-0015 | |
Dr. Vernon Farthing, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 3502 9th St, Ste. 210, Lubbock, TX 79415 Phone: 806-762-8461 | |
Ashref Mohamed, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3415 19th St, Lubbock, TX 79410 Phone: 806-725-4130 | |
Sima Lina Shahbandar, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3601 4th St # Ms 9410, Lubbock, TX 79430 Phone: 806-743-6840 |